Fletcher Allen, a Vermont university hospital and medical center, serves all of
Vermont and the northern New York region. Located in Burlington, Fletcher Allen is a regional, academic healthcare center and teaching hospital in alliance with the University of Vermont.
Clinical Trials at Fletcher Allen/UVM
 |
Clinical trials are research studies involving patients who volunteer to participate in the investigation of new therapies and medications. Clinical trials can offer patients immediate access to treatments not available anywhere else. At Vermont's academic medical center, there are more than 1,000 currently active clinical trials across many fields of medicine.
Clinical Trial Spotlight: Fletcher Allen Begins New Heart Surgery Trial (TAVI)
Fletcher Allen is one of only 45 hospitals nationally now participating in a new U.S. clinical trial to evaluate a revolutionary treatment for a common heart disease, severe aortic stenosis. These heart surgery procedures are part of a research study called TAVI (transcatheter aortic valve implantation) that is designed to determine whether this treatment can be approved for use in the U.S for treating older patients with aortic stenosis.
Would you like to learn more?
If you are interested in learning more about the TAVI clinical trial, please contact the Cardiology Research Office at (802) 847-4746.
If you would like to find out more about other open trials, please contact us or visit the Office of Clinical Trials Research.
Office of Clinical Trials Research
UHC Campus
1 South Prospect Street
Arnold Building, Level 3, Room 3437
Burlington, VT 05401
(802) 656-8990
clinicaltrials@uvm.edu
